AKERS BIOSCIENCES, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the District of New Jersey against Akers Biosciences, Inc.

Lead Plaintiff Deadline is August 13, 2018NEW YORK, July 09, 2018 (GLOBE NEWSWIRE) — Wolf Haldenstein Adler Freeman & Herz LLP announces that a class action lawsuit has been filed in the United States District Court for the District of New Jersey on behalf...

Helix BioPharma Corp. Closes Private Placement

RICHMOND HILL, Ontario, July 09, 2018 (GLOBE NEWSWIRE) — Helix BioPharma Corp. (TSX:HBP) (FSE:HBP) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced it has...